Yejin Chai

YeJin Chai is a highly experienced professional in the biotechnology and investment sectors, currently serving as a Senior Review Officer and Head of Bio Investment at SK증권 since October 2021. Additionally, YeJin Chai has been the Team Leader at NVESTOR since April 2021, focusing on bio-venture investment and business planning. Previous roles include Manager at Genexine, Inc., where responsibilities encompassed business planning and R&D strategy, as well as Assistant Manager at Chong Kun Dang Pharm., specializing in external innovation projects and drug valuation. YeJin Chai's academic credentials include a Ph.D. in Cell Biology and Neuroscience from The University of Queensland, along with a Master's degree in Medicine from Seoul National University and a Bachelor's degree in Bioengineering from the University of Melbourne.